Brain iron MRI: A biomarker for amyotrophic lateral sclerosis

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 6, 2013, Pages 1472-1479

  Ignjatović, Aleksandar ^a   Stević, Zorica ^a   Lavrnić, Slobodan ^b   Daković, Marko ^a,b   Bačić, Goran ^a,c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c National Cancer Research Center   (Serbia)

Author keywords

amyotrophic lateral sclerosis; biomarkers; brain iron; MRI

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MAGNETISM; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; BIOMARKERS; BRAIN IRON; MRI;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; BRAIN; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 84890079933     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24121     Document Type: Article

References (56)

1. Beghi E, Logroscino G, Chio A, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 2006; 1762: 1150-1157.
2. Bruijn LI, Miller TM, Cleveland DW,. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27: 723-749.
3. Brooks BR, Miller RG, Swash M, Munsat TL,. El Escorial revisited:revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
4. Turner MR, Kiernan MC, Leigh PN, Talbot K,. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009; 8: 94-109.
5. Ellis CM, Simmons A, Dawson JM, Williams SCR, Leigh PN, Distinct hyperintense MRI signal changes in the corticospinal tracts of a patient with motor neuron disease. ALS and other motor neuron disorders 1999; 1: 41-44.
6. Hecht MJ, Fellner F, Fellner C, Hilz MJ, Heuss D, Neundorfer B,. MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images. J Neurol Sci 2001; 186: 37-44.
7. Zhang L, Ulug AM, Zimmerman RD, Lin MT, Rubin M, Beal MF,. The diagnostic utility of FLAIR imaging in clinically verified amyotrophic lateral sclerosis. J Magn Reson Imaging 2003; 17: 521-527.
8. Ngai S, Tang YM, Du L, Stuckey S, Hyperintensity of the precentral gyral subcortical white matter and hypointensity of the precentral gyrus on fluid-attenuated inversion recovery: variation with age and implication for the diagnosis of amyotrophic lateral sclerosis, AJNR Am J Neuroradiol 2007; 28: 250-254.
9. Elis CM, Simmons A, Jones DK, et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999; 53: 1051-1058.
10. Hong YH, Lee KW, Sung JJ, Chang KH, Song IC,. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci 2004; 227: 73-78.
11. Wang S, Poptani H, Woo JH, et al. Amyotrophic lateral sclerosis: diffusion-tensor imaging and chemical shift MR imaging at 3.0 T. Radiology 2006; 239: 831-838.
12. Wong JCT, Concha L, Beaulie C, Johnston W, Allen PS, Kaira S,. Spatial profiling of the coricospinal tract in amyotrophic lateral sclerosis using diffusion tensor imaging. J Neuroimaging 2007; 17: 234-240.
13. Charil A, Corbo M, Filippi M, et al. Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric study. Amyotroph Lateral Scler 2009; 10: 269-279.
14. Agosta F, Pagani E, Petrolini M, et al. MRI predictors of long-term evolution in amyotrophic lateral sclerosis. Eur J Neurosci 2010; 32: 1490-1496.
15. Pyra T, Hui B, Hanstock C, et al. Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis. Amyotrophic Lateral Scler 2010; 11: 157-165.
16. Grosskreutz J, Kaufmann J, Fradrich J, Dengler R, Heinze HJ, Peschel T,. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol 2006; 6: 17.
17. Mezzapesa DM, Ceccarelli A, Dicuonzo F, et al. Whole-brain and regional atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2007; 28: 255-258.
18. Rule R, Schuff N, Miller R, Weiner M, Gray matter perfusion correlates with disease severity in ALS, Neurology 2010; 74: 821-827.
19. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R,. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007; 4: 371-386.
20. Schenck JF, Zimmerman EA,. High-field magnetic resonance imaging of brain iron: birth of biomarker? NMR Biomed 2004; 17: 433-445.
21. Bartzokis G, Sultzer D, Cummings J, et al. In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry 2000; 57: 47-53.
22. Langkammer C, Enziger C, Quasthoff S, et al. Mapping of iron deposition in conjunction with assessment of nerve fiber tract integrity in amyotrophic lateral sclerosis. J Magn Reson Imaging 2010; 31: 1339-1345.
23. Oba H, Araki T, Ohtomo H, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993; 189: 843-846.
24. Ishikawa K, Nagura H, Yokota T, Yamonauchi H,. Signal loss in the motor cortex on magnetic resonance imaging in amyotrophic lateral sclerosis. Ann Neurol 1993; 33: 218-222.
25. Cheung G, Gawal MJ, Cooper PW, Farb RI, Ang LC, Amyotrophic Lateral Sclerosis: correlation of clinical and MR imaging findings, Radiology 1995; 194: 263-270.
26. Basak M, Erturk M, Oflazoglu B, et al. Magnetic resonance imaging in amyotrophic lateral sclerosis. Acta Neurol Scand 2002; 105: 395-399.
27. Hecht MJ, Fellner F, Fellner C, et al. Hyperintense and hypointense MRI signals of the precentral gyruses and corticospinal tract in ALS: a follow-up examination including FLAIR images. J Neurol Sci 2002; 199: 59-65.
28. Hecht MJ, Fellner C, Schmid A, Neundorfer B, Fellner FA,. Cortical T2 signal shortening in amyotrophic lateral sclerosis is not due to iron deposits. Neuroradiology 2005; 47: 805-808.
29. Wong JCT, Concha L, Beaulleu C, Johnston W, Allen PS, Kalra S,. Spatial profiling of the corticospinal tract in amyotrophic lateral sclerosis using diffusion tensor imaging. J Neuroimaging 2007; 17: 234-240.
30. Brooks BR, Miller RG, Swash M, Munsat TL,. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
31. Duyn JH,. High-field MRI of brain iron. Methods Mol Biol 2011; 711: 239-249.
32. Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M,. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A 2007; 104: 11796-11801.
33. Toosy AT, Werring DJ, Orrell, RW, et al. Diffusion tensor imaging detects corticospinal tract involmenent at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003; 74: 1250-1257.
34. Blain CRV, Williams VC, Johnston C, et al. A longitudinal study of diffusion tensor MRI in ALS. Amyotrop Lateral Scler 2007; 8: 348-355.
35. Agosta F, Rocca MA, Valsasina P, et al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in ALS patients. J Neurol Neurosurg Psychiatry 2009; 80: 53-55.
36. Sarchielly P, Pelliccolli GP, Tarducci R, et al. Magnetic resonance imaging and (1)H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001; 43: 189-197.
37. Elis CM, Simmons A, Andrews C, Dawson JM, Williams SCR, Leigh PN,. A proton magnetic resonance spectroscopic study in ALS. Correlation with clinical findings. Neurology 1998; 51: 1104-1109.
38. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW,. Decrease in N-acetylaspartate in motor cortex and cerebrospinal tract in ALS. Neurology 1998; 50: 1800-1805.
39. Pohl C, Block W, Karitzky J, et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001; 58: 729-735.
40. Yin H, Lim CCT, Ma L, et al. Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J Neurol 2004; 251: 1249-1254.
41. Suhy J, Miller RG, Rule R, et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology 2002; 58: 773-779.
42. Bowen BC, Pattany PM, Bradley WG, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2000; 21: 647-658.
43. Langkammer C, Krebs N, Goessler W, et al. Quantitative imaging of brain iron: a postmortem validation study. Radiology 2010; 257: 455-462.
44. Graham JM, Paley MN, Grunewald RA, Hoggard N, Griffiths PD,. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000; 123: 2423-2431.
45. Michaeli S, Oz G, Sorce DJ, et al. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov Disord 2007; 22: 334-340.
46. Sage CA, Peeters RR, Gorner A, Robberecht W, Sunaert S,. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimaging 2007; 34: 486-499.
47. Kumar M, Abdel-Dayem HM, Three generations of amyotrophic lateral sclerosis in a family: SPECT brain perfusion findings. Clin Nucl Med 1999; 24: 539-540.
48. Fukunaga M, Li TQ, van Gelderen P, et al. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A 2010; 107: 3834-3839.
49. Bačić G, Liu KJ, O'Hara JA, et al. Oxygen tension in murine tumor: a combined EPR and MRI study. Magn Reson Med 1993; 30: 568-572.
50. Liu KJ, Bačić G, Hoopes PJ, et al. Assessment of cerebral pO2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gas. Brain Res 1995; 685: 91-98.
51. Li X, Jankovic J, Le W,. Iron chelation and neuroprotection in neurodegenerative diseases. J Neural Transm 2011; 118: 473-477.
52. Toshihiko Y, Makoto T, Akemi S, Shunsaku H,. Activated microglia cause superoxide-mediated release of iron from ferritin. Neurosci Lett 1995; 190: 21-24.
53. Perez CA, Tong Y, Guo M,. Iron chelators as potential therapeutic agents for Parkinson's disease. Curr Bioact Compd 2008; 4: 150-158.
54. Kupershmidt L, Weinreb O, Amit T, et al. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 2009; 23: 3766-3779.
55. Wang Q, Zhang X, Chen S, Zhang S, Youdium M, et al. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis. Neurodegener Dis 2011; 8: 310-321.
56. Kwan JY, Jeong SY, van Gelderen P, et al. Iron Accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathology. PLoS ONE 2012; 7: e35241.